280 reports of this reaction
2.2% of all ACETAMINOPHEN, CAFFEINE reports
#6 most reported adverse reaction
MIGRAINE is the #6 most commonly reported adverse reaction for ACETAMINOPHEN, CAFFEINE, manufactured by Haleon US Holdings LLC. There are 280 FDA adverse event reports linking ACETAMINOPHEN, CAFFEINE to MIGRAINE. This represents approximately 2.2% of all 12,550 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, CAFFEINE who experience migraine should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MIGRAINE is a less commonly reported adverse event for ACETAMINOPHEN, CAFFEINE, but still significant enough to appear in the safety profile.
In addition to migraine, the following adverse reactions have been reported for ACETAMINOPHEN, CAFFEINE:
The following drugs have also been linked to migraine in FDA adverse event reports:
MIGRAINE has been reported as an adverse event in 280 FDA reports for ACETAMINOPHEN, CAFFEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MIGRAINE accounts for approximately 2.2% of all adverse event reports for ACETAMINOPHEN, CAFFEINE, making it a notable side effect.
If you experience migraine while taking ACETAMINOPHEN, CAFFEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.